A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study evaluates the PK, safety, and tolerability of a single increasing dose of VH4367310, a cabotegravir (CAB) prodrug, when administered intramuscularly in healthy adult participants 18 to 55 years of age.
Epistemonikos ID: c6da8bc6952cb344056ae670de8e8e184984ad9e
First added on: Sep 15, 2026